Overview
Support Groups
Latest News
Events
Clinical Trials
Mucopolysaccharidosis type II
-
Jan 30, 2019 www.mmahotstuff.com
Denali Therapeutics Inc (NASDAQ:DNLI) Could Burn Your Long Portfolio After More Shorts – MoneyMakingArticles
Read More -
Jan 30, 2019 whatsonthorold.com
Denali Therapeutics Inc (NASDAQ:DNLI) Can’t Be More Risky. Short Interest Increased | Thorold News – Thorold News
Read More -
Jan 30, 2019 moveefy.com
REGENXBIO Inc. (RGNX) and Intrexon Corporation (NASDAQ:XON) Comparison side by side – The Moveefy
Read More -
Jan 30, 2019 www.fairfieldcurrent.com
Regenxbio (RGNX) Upgraded by Zacks Investment Research to “Buy” – Fairfield Current
Read More -
Jan 30, 2019 moveefy.com
Reviewing Denali Therapeutics Inc. (DNLI)’s and Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)’s results – The Moveefy
Read More -
Jan 30, 2019 finexaminer.com
REGENXBIO Inc. (RGNX) and Allogene Therapeutics Inc. (NASDAQ:ALLO) Comparison side by side – The FinExaminer
Read More -
Jan 30, 2019 moveefy.com
Contrasting of Onconova Therapeutics Inc. (ONTX) and REGENXBIO Inc. (NASDAQ:RGNX) – The Moveefy
Read More -
Jan 29, 2019 finheadlines.com
Denali Therapeutics Inc. (DNLI) and Aeterna Zentaris Inc. (NASDAQ:AEZS) Comparing side by side – The FinHeadLines
Read More -
Jan 29, 2019 moveefy.com
Denali Therapeutics Inc. (DNLI) Reaches $19.62 After 3.00% Down Move; Heartland Express Has 1.29 Sentiment – The Moveefy
Read More
